234 related articles for article (PubMed ID: 360797)
1. BCG in tumor immunotherapy.
Baldwin RW; Pimm MV
Adv Cancer Res; 1978; 28():91-147. PubMed ID: 360797
[No Abstract] [Full Text] [Related]
2. BCG as adjuvant immunotherapy for neoplasia.
Hersh EM; Gutterman JU; Mavligit GM
Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
[No Abstract] [Full Text] [Related]
3. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
Mathé G
Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
[No Abstract] [Full Text] [Related]
4. Nonspecific immunotherapy of malignant tumors.
Milas L; Withers HR
Radiology; 1976 Jan; 118(1):211-8. PubMed ID: 1105663
[TBL] [Abstract][Full Text] [Related]
5. [A review on mechanism of anti-tumor action of BCG (author's transl)].
Tokunaga T
Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
[No Abstract] [Full Text] [Related]
6. Activated macrophages and the antitumor action of BCG.
Alexander P
Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
[No Abstract] [Full Text] [Related]
7. The role of immunology in the diagnosis and treatment of cancer.
Humphrey LJ; Pierce GE
Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
[No Abstract] [Full Text] [Related]
8. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
Jessup JM; Riggs CW; Hanna MG
Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
[No Abstract] [Full Text] [Related]
9. Immunotherapy of human leukemia.
Baker MA; Taub RN
Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
[No Abstract] [Full Text] [Related]
10. Modulation of antitumor immunity--immunobiologic approaches.
North RJ; Dye ES; Mills CD; Chandler JP
Springer Semin Immunopathol; 1982; 5(2):193-220. PubMed ID: 6293113
[No Abstract] [Full Text] [Related]
11. Approaches to immunotherapy.
McKhann CF; Gunnarsson A
Cancer; 1974 Oct; 34(4 Suppl):suppl:1521-31. PubMed ID: 4608719
[No Abstract] [Full Text] [Related]
12. Immunotherapy of malignancy in humans. Current status.
Holmes EC; Eilber FR; Morton DL
JAMA; 1975 Jun; 232(10):1052-5. PubMed ID: 236402
[TBL] [Abstract][Full Text] [Related]
13. A guinea pig model for tumor immunology. A summary.
Rapp HJ
Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812
[No Abstract] [Full Text] [Related]
14. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
[No Abstract] [Full Text] [Related]
15. Immunotherapy of human cancer.
Hersh EM; Gutterman JU; Mavligit GM
Adv Intern Med; 1977; 22():145-85. PubMed ID: 65906
[No Abstract] [Full Text] [Related]
16. Immunological adjuvants in cancer immunotherapy.
Baldwin RW
Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
[No Abstract] [Full Text] [Related]
17. Role of BCG immunotherapy in malignant disease.
Hersh EM; Gutterman JU; Mavligit GM; Reed RC
South Med J; 1975 Jun; 68(6):673-5. PubMed ID: 1169816
[No Abstract] [Full Text] [Related]
18. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
Ogura T
Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
[No Abstract] [Full Text] [Related]
19. Use of BCG in the treatment of human neoplasms: a review.
Nathanson L
Semin Oncol; 1974 Dec; 1(4):337-50. PubMed ID: 4620439
[No Abstract] [Full Text] [Related]
20. Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer.
Currie GA
Br J Cancer; 1972 Jun; 26(3):141-53. PubMed ID: 4114812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
